Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Apr 20, 2021DarioHealth will Provide Remote Patient Monitoring Services to MediOrbis for New Offering to Medicare Patients with DiabetesDarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of a new virtual care initiative with MediOrbis, a telehealth provider...
- Mar 9, 2021Significant progress across all pillars of long term strategic operating plan
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 and provided a corporate and...
- Mar 5, 2021
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company will participate in the upcoming Stephens 2021 Best Ideas Conference...
- Mar 2, 2021Clinical Study Shows Increased Digital Engagement Resulted in 43% Improvement in Blood Glucose Levels
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the results of a new clinical study that have been published in the Journal of Medical...
-
Mar 1, 2021Company to host conference call and webcast 8:30 am ET
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the fourth quarter and full year ended December...
- Feb 23, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Cowen 41st Annual Health Care...
-
Feb 19, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Erez Raphael, Chief Executive Officer, is scheduled to participate and host...
- Jan 27, 2021Expands DarioHealth's multi-condition platform into the $213 billion musculoskeletal market and creates one of the most comprehensive digital health platforms
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the signing of a definitive agreement to acquire digital musculoskeletal (MSK) company...
-
Jan 21, 2021Digital health executive Chris Chan held prior roles at Mercer, Willis Towers Watson, and SleepQuest
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. Mr. Chan will...
-
Jan 13, 2021Dr. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Dr. Marilyn Ritholz and Dr. David Horwitz will join Chairman Eric Milledge on its...